California continues to lead the nation in HMO enrollment, with 55% of the state's population participating in an HMO plan, according to a survey released by Medical Data International, Santa Ana, CA.
California continues to lead the nation in HMO enrollment, with 55% of the state's population participating in an HMO plan, according to a survey released by Medical Data International, Santa Ana, CA.
Two-thirds of the 50 states - a total of 33 - increased in HMO enrollment since last year's survey. Highest increases were east of the Mississippi, with Pennsylvania's HMO penetration climbing 15% over the previous year.
Although the West Coast, especially California, continued to show strong numbers, enrollments in Oregon and Utah actually dropped slightly (3% and 2%, respectively). Another dozen states remained essentially flat.
According to the survey, states reporting lowest enrollments tended to be in the northern part of the country. These included Alaska, with virtually no HMO enrollees, and Wyoming and North Dakota, with 3% each. Lowest enrolling Metropolitan Statistical Areas were in the Midwest and the South: Greenville, SC, tallied 14%; Birmingham, AL, 18%; and New Orleans, and Wichita, KS, each totaled 24%.
MDI also looked at 65 large metropolitan statistical areas. In most (80%) of these major population centers, at least one-third of residents are now enrolled in HMO plans, when only about half of the MSAs showed enrollments of one-third or more. According to the survey, the highest enrolling MSA in the country is now Sacramento, CA, at 82% penetration, followed by San Francisco, with 72%. Rochester, NY, the previous year's leader, fell to third place, at 68%.
HMO penetration data for all states and the 65 MSAs is reported in visual format on the 2000 version of MDI's annual "Managed Care Profile Map," a four-color, poster-size graphic. More information is available on MDI's Web site: www.medicaldata.com. PR
The Weight-Loss Gold Rush: Legal and Regulatory Implications
July 11th 2024Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, what needs to be done for GLP-1s to be covered, advice for investors and financiers considering entering the weight-loss medication market and more.
Healthcare Marketing Strategies for Reaching Diverse Audiences
May 14th 2024Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.